Development and Validation of the Promising PPAR Signaling Pathway-Based Prognostic Prediction Model in Uterine Cervical Cancer

Figure 3

(a) The immune infiltration analysis between low- and high-PPAR groups; the correlation between PPAR score and CD274 (b); HAVCR2 (c); PDCD1 (d); CTLA4 (e); LAG3 (f); PDCD1LG2 (g).

(a)

(b)

(c)

(d)

(e)

(f)

(g)